Treatment of acute graft-versus-host disease with low-dose, alternate-day antithymocyte globulin

Haematologica

Volumn 87, Issue 9, 2002, Pages 973-978

  Graziani, Francesco ^a   Van Lint, Maria Teresa ^a   Dominietto, Alida ^a   Raiola, Anna Maria ^a   Di Grazia, Carmela ^a   Lamparelli, Teresa ^a   Gualandi, Francesca ^a   Bregante, Stefania ^a   Fiorone, Merilù ^a   Bruno, Barbara ^a   Bacigalupo, Andrea ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute graft versus host disease; Allogeneic bone marrow transplantation; Antithymocyte globulin

Indexed keywords

CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; SANGSTAT; STEROID; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; GRAFT VERSUS HOST REACTION; HUMAN; MORALITY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADULT; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; INFECTION; MIDDLE AGED; SURVIVAL RATE; TIME FACTORS;

EID: 6444244953     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E, et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67:397-406.
2. Deeg HJ, Henslee-Downey PJ. Management of acute graftversus-host disease. Bone Marrow Transplant 1990; 6:1-8.
3. Henslee Downey PJ. Treatment of acute graft versus host disease. In: Atkinson K, ed. Graft vs Host Disease. New York: Marcel Dekker, Inc; 1990. p. 487.
4. Van Lint MT, Uderzo C, Locasciulli A, Majolino I, Scime R, Locatelli F, et al. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood 1998; 92: 2288-93.
5. Weiden PL, Doney K, Storb R,Thomas ED. Anti-human thymocyte globulin for prophylaxis and treatment of graftversus-host disease in recipients of allogeneic marrow graft. Transplant Proc 1978; 10:213-6.
6. Doney KC, Weiden PL, Storb R, Thomas ED. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 1981: 11:1-8.
7. Deeg HJ, Loughran TP Jr, Storb R, Kennedy MS, Sullivan KM, Doney K, et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 1985; 40:162-6.
8. Dugan MJ, DeFor TE, Steinbuch M, Filipovich AH, Weisdorf DJ. ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival. Ann Hematol 1997; 75:41-6.
9. Cragg L, Blazar BR, Defor T, Kolatker N, Miller W, Kersey J, et al. A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease. Biol Blood Marrow Transplant 2000; 6:441-7.
10. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, Bonnefoy-Berard N. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by poly-clonal antithymocyte globulins. Blood 1998; 91:2360-8.
11. Merion RM, Howell T, Bromberg JS. Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin. Transplantation 1998; 65:1481-9.
12. Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N, et al. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood 1990; 75:1024-30.
13. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76:1464-72.
14. Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB, et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991; 77:1821-8.
15. Roy J, McGlave PB, Filipovich AH, Miller WJ, Blazar BR, Ramsay NK, et al. Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. Bone Marrow Transplant 1992; 10: 77-82.
16. Aschan J. Treatment of moderate to severe acute graftversus-host disease: a retrospective analysis. Bone Marrow Transplant 1994; 14:601-7.
17. MacMillan MIL, Weisdorf DJ, Davies SM, DeFor TE, Burns LJ, Ramsay NK, et al. Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8:40-6.